1·Laboratory: increase Prothrombin time (PT).
实验室检查：凝血酶原时间(PT)延长。
2·Objective: to investigate the part influence factors of prothrombin time assay.
目的：探讨凝血酶原时间测定的部分影响因素。
3·Objective to explore effects of blood platelets and prothrombin time on mifepristone.
目的探讨米非司酮对血小板、血浆凝血酶原时间的影响。
4·Patients with hypoproteinemia or prolonged prothrombin time (PT) were often accompanied by hypocalcemia.
低蛋白血症和PT延长的病例伴有低血钙较常见。
5·The majority of patients with ascites due to cirrhosis have prolongation of the prothrombin time and some degree of thrombocytopenia.
大多数肝硬化腹水的患者凝血酶原时间延长并有一定程度的血小板减少。
6·However, there was no significant difference in the total bilirubin and prothrombin time in either group during the observation periods.
然而，观察期间在总胆红素和凝血酶原时间方面两组之间没有显著差异。
7·The prothrombin time(PT) and the active partial thromboplastin time(APTT) were measured by the ACL- 200 antomatic blood agglutination instrument.
用ACL-200型血液凝集仪测定大鼠凝血酶原时间（PT）和部分凝血活酶时间（APTT）。
8·Objective: to monitor the curative effect of oral warfarin for the patients after heart mechanical valve displacement by the prothrombin time (PT).
目的评价采用凝血酶原时间(PT)监测心脏机械型瓣膜置换术后患者口服华法林治疗效果的意义。
9·We found ABP prolonged coagulation time (CT) in mice, increased plasma prothrombin time (PT) and kaolin partial thromboplastin time (KPTT) in rats.
发现怀牛膝多糖a BP能延长小鼠凝血时间(CT)、大鼠血浆凝血酶原时间(PT)、白陶土部分凝血活酶时间(K PTT)。
10·The result of liver function, renal function, electrolyte, prothrombin time activity (PTa), blood routine before and after the treatment were analyzed.
比较了血浆置换前后患者临床症状、肝肾功能、电解质、凝血酶原活动度、血常规变化等。